BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11514052)

  • 1. Endocrine regulation of testicular function in men: implications for contraceptive development.
    Amory JK; Bremner W
    Mol Cell Endocrinol; 2001 Sep; 182(2):175-9. PubMed ID: 11514052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of testicular function in men: implications for male hormonal contraceptive development.
    Amory JK; Bremner WJ
    J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):357-61. PubMed ID: 12943722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developments in the control of testicular function.
    Swerdloff RS; Wang C; Bhasin S
    Baillieres Clin Endocrinol Metab; 1992 Apr; 6(2):451-83. PubMed ID: 1377467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiological relationships between inhibin B, follicle stimulating hormone secretion and spermatogenesis in normal men and response to gonadotrophin suppression by exogenous testosterone.
    Anderson RA; Wallace EM; Groome NP; Bellis AJ; Wu FC
    Hum Reprod; 1997 Apr; 12(4):746-51. PubMed ID: 9159436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional analysis of recombinant single-chain Japanese eel Fsh and Lh produced in FreeStyle 293-F cell lines: Binding specificities to their receptors and differential efficacy on testicular steroidogenesis.
    Suzuki H; Kazeto Y; Gen K; Ozaki Y
    Gen Comp Endocrinol; 2020 Jan; 285():113241. PubMed ID: 31400434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
    Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM; Gow SM; Wu FC
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.
    Behre HM; Nashan D; Hubert W; Nieschlag E
    J Clin Endocrinol Metab; 1992 Jan; 74(1):84-90. PubMed ID: 1727833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
    Matsumoto AM
    J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active immunization with GnRH-tandem-dimer peptide in young male rats reduces serum reproductive hormone concentrations, testicular development and spermatogenesis.
    Han XF; Li JL; Zhou YQ; Ren XH; Liu GC; Cao XH; Du XG; Zeng XY
    Asian J Androl; 2016; 18(3):485-91. PubMed ID: 26208395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug insight: Recent advances in male hormonal contraception.
    Amory JK; Page ST; Bremner WJ
    Nat Clin Pract Endocrinol Metab; 2006 Jan; 2(1):32-41. PubMed ID: 16932251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel peptides in ovarian follicular fluid: implications for contraceptive development.
    Schwartz NB
    Res Front Fertil Regul; 1982 Sep; 2(2):1-11. PubMed ID: 12179632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of testosterone as a male contraceptive.
    Amory JK; Bremner WJ
    Baillieres Clin Endocrinol Metab; 1998 Oct; 12(3):471-84. PubMed ID: 10332567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting pituitary gonadotropin function in users of oral contraceptive steroids.
    Scott JA; Brenner PF; Kletzky OA; Mishell DR
    Am J Obstet Gynecol; 1978 Apr; 130(7):817-21. PubMed ID: 345817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leydig cells.
    Neaves WB
    Contraception; 1975 May; 11(5):571-606. PubMed ID: 1095296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone/progestin regimens: a realistic option for male contraception?
    Amory JK
    Curr Opin Investig Drugs; 2004 Oct; 5(10):1025-30. PubMed ID: 15535423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothalamic-pituitary-gonadal axis in two men with aromatase deficiency: evidence that circulating estrogens are required at the hypothalamic level for the integrity of gonadotropin negative feedback.
    Rochira V; Zirilli L; Genazzani AD; Balestrieri A; Aranda C; Fabre B; Antunez P; Diazzi C; Carani C; Maffei L
    Eur J Endocrinol; 2006 Oct; 155(4):513-22. PubMed ID: 16990650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Male hormonal contraceptives: current status and future prospects.
    Amory JK
    Treat Endocrinol; 2005; 4(6):333-41. PubMed ID: 16318399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An
    Arato I; Luca G; Mancuso F; Bellucci C; Lilli C; Calvitti M; Hansen BC; Milardi D; Grande G; Calafiore R
    Asian J Androl; 2018; 20(2):160-165. PubMed ID: 29148520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrinology of male infertility.
    de Kretser DM
    Br Med Bull; 1979 May; 35(2):187-92. PubMed ID: 387166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.